M W Casewell, R L Hill. Show Affiliations »
Abstract
Entities: Species
Mesh: See more » Carrier State/drug therapyCarrier State/microbiologyCross Infection/drug therapyCross Infection/microbiologyCross Infection/transmissionDisease OutbreaksFatty Acids/therapeutic useHumansMethicillin/pharmacologyMethicillin/therapeutic useMupirocinNasal Cavity/microbiologyPenicillin ResistancePerineum/microbiologyPersonnel, HospitalSkin/microbiologyStaphylococcal Infections/drug therapyStaphylococcal Infections/microbiologyStaphylococcal Infections/transmissionStaphylococcus aureus/drug effectsStaphylococcus aureus/isolation & purification
Substances: See more » Fatty AcidsMupirocinMethicillin
Year: 1986 PMID: 3091562 DOI: 10.1093/jac/18.supplement_a.1
Source DB: PubMed Journal: J Antimicrob Chemother ISSN: 0305-7453 Impact factor: 5.790